INTRODUCTION {#sec1}
============

Infertility is a serious health problem that occurs in approximately 10% of all families worldwide and may affect couples living in developing countries even more \[[@cit0001]\]. It can be defined as the failure to conceive despite one year of regular and unprotected intercourse. Endocrine disorders, environmental factors, reactive oxygen radicals, diet, genetic and epigenetic factors have been implicated in the etiology of infertility. Abnormal sperm parameters cause infertility in approximately 50% of couples without children. In 30--40% of couples, the female partner was determined to be fertile, however none of the infertility factors were detected in male partners, and thus these men were diagnosed with idiopathic male infertility. One in six of these pairs present with secondary infertility, whereas primary infertility occurs in one in eight pairs \[[@cit0002]\].

Obesity is a health-threatening problem with a worldwide prevalence \[[@cit0003]\]. The relationship between increase in adipose tissue and subfertility has not been clearly demonstrated in the literature yet. However, it has been emphasized that the risk of infertility increases if the male partner is overweight or obese \[[@cit0004]\]. It has also been reported that increase in adipose tissue negatively affects female fertility \[[@cit0005]\]. Continuity of spermatogenesis and sperm quality depend on high levels of intratesticular testosterone \[[@cit0006]\]. Increasing body mass index (BMI) and decreasing testosterone levels may negatively affect spermatogenesis and several factors such as decreased levels of sex hormone-binding globulin, increased levels of leptin and increased aromatase activity in adipose tissue have been implicated in the etiology \[[@cit0007]\].

The BMI's effect on semen quality and reproductive hormone levels is not well-known. The aim of this study was to evaluate the relationship between BMI and sperm parameters and reproductive hormone levels in patients with no known risk factors for infertility.

MATERIAL AND METHODS {#sec2}
====================

This retrospective study included patients admitted to our urology clinic due to infertility between January 2018 and June 2019. After approval from the local ethics committee (approval number: 2017-KAEK-189_2019.06.19_08), patients 18 years and older were included in the study. Informed consent was obtained from all patients included in the study. The study was performed in accordance with the declaration of Helsinki. Patients with known risk factors that may affect sperm parameters such as varicocele, history of scrotal surgery (undescended testis, testis tumour, varicocelectomy history in last 6 months), solitary testis, hormonal disorders (diabetes mellitus, hypogonadism, hypo/hyperthyroidism, hyperprolactinemia, etc.), genital tract infection (orchitis, epididymitis, urethritis, etc.), neurologic and psychological disorders and history of medication, chemotherapy and alcohol and tobacco consumption were excluded from the study. Also, patients whose female partners' gynecological examinations revealed abnormalities were excluded from the study. Moreover, patients with azoospermia and cryptozoospermia (≤1 million/ml) were also excluded from the study. Age, BMI, type of infertility, duration of infertility, levels of follicle stimulating hormone (FSH) (0.95--12.5 mIU/ml), luteinizing hormone (LH) (1.5--8.5 mIU/ml), total testosterone (T) (200-950 ng/dl), estradiol (E2) (7.6--42.6 ng/L), and prolactin (PRL) (3.4--19.4 ng/ml), as well as testosterone/estradiol (T/E2) ratios, and semen parameters of 400 patients who met the study's inclusion criteria we recorded. Hormone levels were measured using the ARCHITECT i2000sr immunoassay analyzer (Abbott Laboratories). In the outpatient examination, the height and weight of the patients were measured and recorded. BMI was calculated by the formula of (weight in kg)/(height in m^2^). Hormonal analysis was performed on the same day as the sperm specimens were collected from the patients who had at least 72 hours of sexual abstinence. The patients were divided into three groups according to their BMI values as normal weight (BMI: 18.5--24.9 kg/m^2^), overweight (BMI: 25--29.9 kg/m^2^), and obese (BMI: ≥30 kg/m^2^) \[[@cit0008]\]. Primary infertility was accepted as a failure to achieve pregnancy despite unprotected regular sexual intercourse for at least 12 months. Secondary infertility was defined as the inability to conceive for some time after the birth of one or more biological children. Semen samples were taken after 3--7 days of sexual abstinence and sperm analysis was performed according to the World Health Organization (WHO) 2010 criteria \[[@cit0009]\]. Sperm analysis results including semen volume, sperm concentration and morphology, total sperm count, progressive and total sperm motility were recorded. The parameters were compared between the three groups divided according to BMI values.

Statistical analyses {#sec2.1}
--------------------

All statistical tests were performed using the Statistical Package for Social Sciences version 25 (IBM SPSS^®^, Chicago, IL). The Kolmogorov-Smirnov test was used to evaluate the data distribution, and a non-parametric test was used for non-normal distributions. Chi-square test was used for categorical data, while Kruskal-Wallis test was used for numerical data. Pairwise multiple comparisons analysis was used to identify the group that provided statistical significance. The relationship between BMI and hormone and semen parameters was determined using Spearman correlation test. A p-value \<0.05 was considered statistically significant.

RESULTS {#sec3}
=======

The patients' demographic characteristics and hormonal profiles are summarized in [Table 1](#t0001){ref-type="table"}. A total of 400 patients were included in the study. Of these patients, 274 (68.5%) were primary infertile, while 126 (31.5%) were secondary infertile. There was no significant difference between the groups in terms of type of infertility. Among the patients presenting with primary infertility, 46.7% (128/274) were overweight and 39.0% (107/274) were in the normal weight group. The majority of the patients with secondary infertility (50.7%) were in the overweight group. The mean age was 30.7 ±5.5 years, the mean infertility period was 2.5 ±2.6 years (median 1.5 years, min-max: 1--21 years). There was no significant difference between the groups in terms of age and infertility period. The mean BMI of all the patients was 26.6 ±4.08, and the BMI in the normal, overweight and obese groups were 22.6 ±1.7, 27.4 ±1.3, and 33.4 ±2.9, respectively (p \<0.001). There was no significant difference between the groups in terms of serum FSH, LH, E2, PRL, semen volume, sperm concentration, total sperm count, and progressive and total motility. Serum T level and T/E2 ratio were significantly higher in the normal BMI group (p \<0.001).

###### 

Demographic and hormonal characteristics of patients according to different BMI groups

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Parameters                                 All patients                   Distribution of groups according to BMI (kg/m^2^)                                                               
  ------------------------------------------ ------------------------------ --------------------------------------------------- ----------------------------- ----------------------------- -------------------------------------------
  Number (n) (%)                             400 (100)                      146 (36.5)                                          192 (48)                      62 (15.5)                     

  BMI (mean ±SD)                             26.6 ±4.0 (18.6--41.5)         22.6 ±1.7 (18.6--24.9)                              27.4 ±1.3 (25.0--29.8)        33.4 ±2.9 (30.0--41.52)       \<0.001

  Age (mean ±SD)                             30.7 ±5.5 (18--54)             30.2 ±5.2 (21--54)                                  31.0 ±5.7 (18--54)            31.2 ±5.5 (21--50)            0.229

  Type of infertility (n) (%)\               \                              \                                                   \                             \                             \
   Primary\                                  274 (68.5)\                    107 (73.3)\                                         128 (66.7)\                   39 (62.9)\                    \
   Secondary                                 126 (31.5)                     39 (26.7)                                           64 (33.3)                     23 (37.1)                     0.253

  Duration of infertility, year (mean ±SD)   2.5 ±2.6                       2.3 ±2.3                                            2.5 ±2.9                      2.6 ±2.4                      0.366

  Serum FSH, mIU/ml(mean ±SD)                3.8 ±2.3 (1.0--12.4)           3.8 ±2.2 (1.2--12.4)                                3.8 ±2.4 (1.0--12.0)          3.7 ±1.9 (1.1--10.9)          0.919

  Serum LH, mIU/ml(mean ±SD)                 3.5 ±1.5 (1.5--8.4)            3.5 ±1.4 (1.5--8.4)                                 3.5 ±1.6 (1.5--8.1)           3.3 ±1.4 (1.5--7.3)           0.472

  Serum T, ng/dl (mean ±SD)                  478.6 ±198.4 (220.4--923.14)   558.7 ±184.7 (221.8--923.1)                         444.5 ±202.3 (225.4--921.4)   395.7 ±149.4 (220.4--832.1)   \<0.001[^a^](#tf1-1){ref-type="table-fn"}

  Serum E2, ng/L (mean ±SD)                  24.4 ±9.9 (10.0--88.0)         23.7 ±9.3 (10.0--63.0)                              24.5 ±10.7 (10.2--88.0)       25.5 ±9.0 (10.6--50.0)        0.315

  Serum PRL, ng/ml (mean ±SD)                9.7 ±4.8 (3.1--16.8)           10.0 ±5.2 (4.5--16.8)                               9.5 ±4.7 (3.2-15.7)           9.9 ±4.0 (3.1--15.4)          0.439

  Semen volume, ml (mean ±SD)                3.2 ±1.4 (1.5--8.5)            3.2 ±1.3 (1.5--7.5)                                 3.3 ±1.5 (1.5--8.5)           3.0 ±1.3 (1.5--6.5)           0.653

  Sperm conc. mil/ml (mean ±SD)              46.6 ±32.3 (1.5--140.5)        44.5 ±32.1 (1.5--120)                               49.0 ±31.4 (2.2--140.5)       44.1 ±35.3 (1.5--120.4)       0.259

  Total sperm, mil (mean ±SD)                152.4 ±128.2 (2.3--812.07)     143.3 ±119.7 (2.3--552.8)                           163.2 ±131.2 (2.5--812.7)     140.0 ±137.7 (2.8--611.4)     0.110

  Progressive motility (type A) (%)          27.5 ±12.8 (0--70)             27.0 ±11.8 (0--50)                                  28.2 ±12.2 (5--60)            26.6 ±16.4 (0--70)            0.618

  Total motility (type A+B) (%)              45.5 ±16.0 (0--80)             44.9 ±15.4 (0--75)                                  46.7 ±14.8 (11--80)           43.2 ±20.1 (578)              0.543

  T/E2 (mean ±SD)                            22.7 ±14.2 (3.1--83.8)         26.6 ±12.7 (7.0--77.6)                              21.3 ±15.7 (4.1--83.8)        17.8 ±9.9 (3.1--56.6)         \<0.001[^b^](#tf1-2){ref-type="table-fn"}
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Pairwise multiple comparisons: normal -- overweight (P ≤0.001); normal -- obese (P ≤0.001); overweight -- obese (P = 0.150)

Pairwise multiple comparisons: normal -- overweight (P ≤0.001); normal -- obese (P ≤0.001); overweight -- obese (P = 0.087)

BMI -- body mass index; SD -- standard deviation; FSH -- follicle stimulating hormone; LH -- luteinizing hormone; T -- testosterone; E2 -- estradiol; PRL -- prolactin; T/E2 -- testosterone/estradiol

The BMI was negatively correlated with semen volume, normal sperm morphology, total sperm count, and T and T/E2 ratio. However, this correlation was significant only with serum T levels and T/E2 ratio (p \<0.001) ([Table 2](#t0002){ref-type="table"}).

###### 

Correlation between BMI and sperm and hormonal parameters

  Parameters                                                       BMI (kg/m^2^)   
  ---------------------------------------------------------------- --------------- ---------
  Semen volume (ml)[^a^](#tf2-1){ref-type="table-fn"}              -0.027          0.596
  Sperm concentration (mil/ml)[^a^](#tf2-1){ref-type="table-fn"}   0.009           0.853
  Normal morphology (%)[^a^](#tf2-1){ref-type="table-fn"}          -0.010          0.148
  Total sperm count (mil)[^a^](#tf2-1){ref-type="table-fn"}        -0.003          0.957
  Serum E2 (ng/L)[^a^](#tf2-1){ref-type="table-fn"}                0.088           0.079
  Serum T (ng/dl)[^a^](#tf2-1){ref-type="table-fn"}                -0.402          \<0.001
  T/E2 ratio                                                       -0.367          \<0.001

Spearman correlation test

BMI -- body mass index, E2 -- estradiol, T -- testosterone, T/E2 - testosterone/estradiol

DISCUSSION {#sec4}
==========

In this study, we excluded patients with known risk factors and aimed to evaluate the relationship between BMI and reproductive hormones and semen parameters. Changes in hormonal and semen parameters are expected in response to increasing adipose tissue that comes with increased BMI \[[@cit0010]\]. According to our results, there was no significant relationship between BMI and semen parameters, however serum T levels and T/E2 ratios differed between the groups and were negatively correlated with increasing BMI.The relationship between obesity, male subfertility and sperm parameters can be multifactorial and different pathophysiological hypotheses have been proposed. Firstly, a decrease in sex hormone binding globulin (SHBG) levels has been shown to be facilitated by hyperinsulinemia caused by insulin resistance due to obesity and by the negative feed-back effect of elevated total E2 levels \[[@cit0004], [@cit0011]\]. Secondly, the increase in leptin levels lead to suppression of the effect of LH on testicular Leydig cells \[[@cit0007]\]. Finally, the reduction of T/E2 ratio due to steroid aromatization in the adipose tissue causes an increase in estrogen levels and leads to hypogonadotropic hyperestrogenic hypogonadism \[[@cit0007]\].

There are conflicting opinions in the literature regarding the correlation between BMI and semen parameters because there is lack of studies evaluating male infertility in obese patients and obesity may be accompanied by comorbid diseases that may affect fertility. Sermondade et al. \[[@cit0004]\] conducted a meta-analysis with 1307 patients and concluded that the increase in BMI negatively affected some semen parameters. Some other studies have also reported that obese males had decreased semen volume, sperm concentration and total sperm count, and had sperm quality disorders 3 times more frequently than the normal group \[[@cit0012], [@cit0013]\]. However, a meta-analysis that included 31 studies reported that increased BMI had no effect on sperm parameters \[[@cit0014]\]. In addition, it was emphasized that fertilization rates were higher in obese men as a result of the in vitro fertilization cycle compared to normal weight men. However, the live birth rate was reported to be lower for the obese patients group \[[@cit0015]\]. When the literature data was analysed, the interaction between the increase of the adipose tissue and the reproductive system was not clearly explained. In our study, we did not find a significant correlation between BMI increase and parameters such as semen volume, sperm morphology, and total sperm count. In addition, we did not see any significant correlation between BMI and sperm motility and ejaculate volume.

There are also studies reporting the negative effect of obesity on motility and ejaculate volume \[[@cit0016], [@cit0017]\]. In a study similar to ours, where the infertility-associated risk factors were excluded, the sperm concentration was found to be negatively correlated with increased BMI \[[@cit0010], [@cit0018]\] but we did not detect any such correlation in our study. It has been reported that differences in standardization used during the sperm's morphological evaluation may cause variability in results \[[@cit0019]\]. While some studies have shown that the increase in adipose tissue is positively correlated with the increase in the rate of morphologically abnormal sperm \[[@cit0020]\] other studies claimed that adiposity had no effect on morphology \[[@cit0010], [@cit0014], [@cit0021]\]. In our study, we did not find any significant correlation between increased adipose tissue and abnormal sperm morphology.

Local hormonal balance of testicular testosterone and estradiol ratio has an impact on spermatogenesis. The deterioration of this balance may lead to infertility by affecting normal spermatogenesis negatively. Thus, evaluating the alteration of T/E2 ratio may give beneficial information \[[@cit0022]\]. A study by Keskin et al. \[[@cit0023]\] conducted with 454 patients reported no significant correlation between BMI increase and semen parameters as well as T/E2 ratio, however a negative correlation between BMI and total testosterone and PRL was observed. In our study, increased BMI was negatively correlated with total testosterone levels and T/E2 ratio, but was not significantly correlated with PRL and gonadotropin levels. Our results are in line with another study that has reported that adiposity significantly reduces T levels, but has no effect on gonadotropin levels \[[@cit0024]\]. The results of our study as well as other studies suggest that obesity negatively affects male reproductive potential by decreasing T levels and T/E2 ratio \[[@cit0011]\].

This study has some limitations due to its retrospective design. Due to the insufficient number of patients, a low-weight group with a BMI of less than 18 could not be established. Furthermore, since the patients included in the study were men presenting with infertility, they may have higher abnormal semen parameters than the general population. The absence of free testosterone measurement and the patients who have sperm count under 5 million without genetic analysis may also be considered a limitation.

CONCLUSIONS {#sec5}
===========

In our study, while adipose tissue increase was not significantly correlated with change in the semen parameters, it was negatively correlated with T levels and T/E2 ratio. Although increased BMI has been shown to adversely affect fertility potential by various mechanisms of action, larger randomized and prospective studies are needed to determine the effects of adiposity on sperm quality, hormonal axis and male infertility.
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